| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | serine hydrolase activity | 7.94e-06 | 212 | 159 | 10 | GO:0017171 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 4.32e-05 | 207 | 159 | 9 | GO:0008236 | |
| GeneOntologyMolecularFunction | carbon-carbon lyase activity | 8.27e-05 | 56 | 159 | 5 | GO:0016830 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 1.45e-04 | 190 | 159 | 8 | GO:0004252 | |
| GeneOntologyMolecularFunction | endopeptidase activity | APEH REN KLK3 OVCH1 PRSS36 LPA TMPRSS2 ATG4C ERVK-19 HABP2 ERVK-25 PLG | 1.76e-04 | 430 | 159 | 12 | GO:0004175 |
| GeneOntologyMolecularFunction | carboxy-lyase activity | 1.87e-04 | 36 | 159 | 4 | GO:0016831 | |
| GeneOntologyMolecularFunction | peptidase activity | APEH REN ERMP1 KLK3 OVCH1 PRSS36 AOPEP LPA TMPRSS2 ATG4C ERVK-19 SCPEP1 HABP2 ERVK-25 PLG | 2.38e-04 | 654 | 159 | 15 | GO:0008233 |
| GeneOntologyMolecularFunction | alpha-1,2-mannosyltransferase activity | 3.74e-04 | 4 | 159 | 2 | GO:0000026 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF, modulating synaptic transmission | 1.57e-05 | 7 | 160 | 3 | GO:0099183 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF | 2.49e-05 | 8 | 160 | 3 | GO:0099191 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 1.44e-04 | 35 | 160 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | SLC37A1 ACSL6 NEU4 HLA-DRB1 HLA-DRB3 INSIG1 ERMP1 IRAG1 PIGZ SLC39A13 RYR1 HHATL GDPD5 GUCY2F OSBPL3 SGPL1 ALG9 RAB3GAP2 GUCY2D SIK2 ATP2A2 TAPBP ACSL5 | 1.98e-04 | 1327 | 160 | 23 | GO:0042175 |
| GeneOntologyCellularComponent | autolysosome membrane | 3.46e-04 | 4 | 160 | 2 | GO:0120281 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | SLC37A1 ACSL6 NEU4 HLA-DRB1 HLA-DRB3 INSIG1 ERMP1 IRAG1 PIGZ SLC39A13 RYR1 HHATL GDPD5 OSBPL3 SGPL1 ALG9 RAB3GAP2 GUCY2D SIK2 ATP2A2 TAPBP ACSL5 | 3.56e-04 | 1293 | 160 | 22 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | SLC37A1 ACSL6 NEU4 HLA-DRB1 HLA-DRB3 INSIG1 ERMP1 IRAG1 PIGZ SLC39A13 RYR1 HHATL GDPD5 OSBPL3 SGPL1 ALG9 RAB3GAP2 GUCY2D SIK2 ATP2A2 TAPBP ACSL5 | 3.79e-04 | 1299 | 160 | 22 | GO:0098827 |
| GeneOntologyCellularComponent | side of membrane | EPOR RASGRP4 ACHE HLA-DRB1 HLA-DRB3 CD109 RYR1 BTN2A2 IGHD LPA ALG9 PLG ADGRE1 ATP2A2 IL3RA TAPBP IL27RA | 4.01e-04 | 875 | 160 | 17 | GO:0098552 |
| GeneOntologyCellularComponent | lumenal side of membrane | 4.95e-04 | 48 | 160 | 4 | GO:0098576 | |
| MousePheno | abnormal mammary gland connective tissue morphology | 8.45e-05 | 2 | 129 | 2 | MP:0009507 | |
| MousePheno | ectropion | 8.45e-05 | 2 | 129 | 2 | MP:0006164 | |
| MousePheno | esophageal ulcer | 8.45e-05 | 2 | 129 | 2 | MP:0004547 | |
| MousePheno | duodenal ulcer | 8.45e-05 | 2 | 129 | 2 | MP:0003273 | |
| MousePheno | perianal ulcer | 8.45e-05 | 2 | 129 | 2 | MP:0005035 | |
| MousePheno | abnormal keratinocyte migration | 1.20e-04 | 11 | 129 | 3 | MP:0012192 | |
| Domain | PyrdxlP-dep_de-COase | 3.11e-07 | 8 | 155 | 4 | IPR002129 | |
| Domain | Pyridoxal_deC | 3.11e-07 | 8 | 155 | 4 | PF00282 | |
| Domain | DDC_GAD_HDC_YDC | 3.11e-07 | 8 | 155 | 4 | PS00392 | |
| Domain | Kringle-like | 6.20e-06 | 32 | 155 | 5 | IPR013806 | |
| Domain | TRYPSIN_HIS | 2.41e-05 | 103 | 155 | 7 | IPR018114 | |
| Domain | - | 2.45e-05 | 21 | 155 | 4 | 2.60.60.20 | |
| Domain | PLAT | 2.45e-05 | 21 | 155 | 4 | PF01477 | |
| Domain | PLAT/LH2_dom | 2.45e-05 | 21 | 155 | 4 | IPR001024 | |
| Domain | PLAT | 2.45e-05 | 21 | 155 | 4 | PS50095 | |
| Domain | TRYPSIN_SER | 2.90e-05 | 106 | 155 | 7 | PS00135 | |
| Domain | TRYPSIN_HIS | 3.08e-05 | 107 | 155 | 7 | PS00134 | |
| Domain | Peptidase_S1A | 4.38e-05 | 113 | 155 | 7 | IPR001314 | |
| Domain | TRYPSIN_DOM | 4.90e-05 | 115 | 155 | 7 | PS50240 | |
| Domain | Tryp_SPc | 5.47e-05 | 117 | 155 | 7 | SM00020 | |
| Domain | Trypsin_dom | 6.78e-05 | 121 | 155 | 7 | IPR001254 | |
| Domain | Trypsin | 6.78e-05 | 121 | 155 | 7 | PF00089 | |
| Domain | Aromatic_deC | 6.84e-05 | 2 | 155 | 2 | IPR010977 | |
| Domain | - | 7.00e-05 | 52 | 155 | 5 | 2.60.120.290 | |
| Domain | Peptidase_S1_PA | 7.52e-05 | 123 | 155 | 7 | IPR009003 | |
| Domain | TRYPSIN_SER | 1.04e-04 | 90 | 155 | 6 | IPR033116 | |
| Domain | CUB_dom | 1.09e-04 | 57 | 155 | 5 | IPR000859 | |
| Domain | EamA | 1.91e-04 | 14 | 155 | 3 | PF00892 | |
| Domain | EamA_dom | 1.91e-04 | 14 | 155 | 3 | IPR000620 | |
| Domain | PROL5-SMR | 2.04e-04 | 3 | 155 | 2 | PF15621 | |
| Domain | SMR-like | 2.04e-04 | 3 | 155 | 2 | IPR026288 | |
| Domain | - | 2.99e-04 | 39 | 155 | 4 | 3.40.640.10 | |
| Domain | Kringle_CS | 3.50e-04 | 17 | 155 | 3 | IPR018056 | |
| Domain | KRINGLE_1 | 3.50e-04 | 17 | 155 | 3 | PS00021 | |
| Domain | KR | 3.50e-04 | 17 | 155 | 3 | SM00130 | |
| Domain | Kringle | 3.50e-04 | 17 | 155 | 3 | IPR000001 | |
| Domain | KRINGLE_2 | 3.50e-04 | 17 | 155 | 3 | PS50070 | |
| Domain | Kringle | 3.50e-04 | 17 | 155 | 3 | PF00051 | |
| Domain | PyrdxlP-dep_Trfase | 3.64e-04 | 41 | 155 | 4 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 3.64e-04 | 41 | 155 | 4 | IPR015421 | |
| Domain | Glyco_transf_22 | 4.06e-04 | 4 | 155 | 2 | PF03901 | |
| Domain | Lipase_panc | 4.06e-04 | 4 | 155 | 2 | IPR002331 | |
| Domain | GPI_mannosylTrfase | 4.06e-04 | 4 | 155 | 2 | IPR005599 | |
| Domain | DAG/PE-bd | 6.68e-04 | 21 | 155 | 3 | IPR020454 | |
| Domain | Pyridoxal-P_BS | 6.73e-04 | 5 | 155 | 2 | IPR021115 | |
| Domain | CUB | 7.23e-04 | 49 | 155 | 4 | PF00431 | |
| Domain | CUB | 7.81e-04 | 50 | 155 | 4 | SM00042 | |
| Domain | CUB | 9.74e-04 | 53 | 155 | 4 | PS01180 | |
| Domain | HNOB_dom_associated | 1.00e-03 | 6 | 155 | 2 | IPR011645 | |
| Domain | HNOBA | 1.00e-03 | 6 | 155 | 2 | PF07701 | |
| Domain | C1-set | 1.05e-03 | 54 | 155 | 4 | PF07654 | |
| Domain | Ig_C1-set | 1.37e-03 | 58 | 155 | 4 | IPR003597 | |
| Domain | IG_MHC | 1.55e-03 | 60 | 155 | 4 | PS00290 | |
| Domain | EGF_2 | 1.69e-03 | 265 | 155 | 8 | PS01186 | |
| Domain | MHC_II_b_N | 1.85e-03 | 8 | 155 | 2 | PD000328 | |
| Domain | Growth_fac_rcpt_ | 1.94e-03 | 156 | 155 | 6 | IPR009030 | |
| Domain | Ig-like_fold | EPOR DSCAM HLA-DRB1 NTRK2 HLA-DRB3 PKHD1L1 KIRREL3 BTN2A2 HMCN2 IGHD IL3RA TAPBP PLXNA1 IL27RA | 2.28e-03 | 706 | 155 | 14 | IPR013783 |
| Domain | MHC_II_b_N | 2.37e-03 | 9 | 155 | 2 | IPR000353 | |
| Domain | MHC_II_beta | 2.37e-03 | 9 | 155 | 2 | SM00921 | |
| Domain | MHC_II_beta | 2.37e-03 | 9 | 155 | 2 | PF00969 | |
| Domain | GPS | 2.78e-03 | 34 | 155 | 3 | SM00303 | |
| Domain | Lipase/vitellogenin | 2.95e-03 | 10 | 155 | 2 | IPR013818 | |
| Domain | TAG_lipase | 2.95e-03 | 10 | 155 | 2 | IPR000734 | |
| Domain | Lipase | 2.95e-03 | 10 | 155 | 2 | PF00151 | |
| Domain | Lipase_N | 2.95e-03 | 10 | 155 | 2 | IPR033906 | |
| Domain | Lipase_LIPH | 2.95e-03 | 10 | 155 | 2 | IPR016272 | |
| Domain | - | 3.02e-03 | 35 | 155 | 3 | 3.90.1150.10 | |
| Domain | GPS | 3.02e-03 | 35 | 155 | 3 | PF01825 | |
| Domain | - | 3.16e-03 | 119 | 155 | 5 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 3.16e-03 | 119 | 155 | 5 | IPR029058 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 3.27e-03 | 36 | 155 | 3 | IPR015422 | |
| Domain | GPS | 3.27e-03 | 36 | 155 | 3 | PS50221 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 SZT2 KIF26A ADGRB2 APEH GEMIN5 CEP192 TEP1 ZZEF1 TRRAP ARSG RYR1 TBC1D17 GDPD5 C2CD3 IGF2R MEGF8 CSAD DENND5A PLXNA1 | 2.20e-07 | 1105 | 161 | 20 | 35748872 |
| Pubmed | Soluble M6P/IGF2R released by TACE controls angiogenesis via blocking plasminogen activation. | 9.67e-07 | 5 | 161 | 3 | 21273553 | |
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 8854860 | ||
| Pubmed | CCL2/MCP-1 signaling drives extracellular matrix turnover by diverse macrophage subsets. | 1.93e-06 | 6 | 161 | 3 | 33543002 | |
| Pubmed | Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling. | 2.02e-06 | 20 | 161 | 4 | 20133625 | |
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 9438420 | ||
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 11562346 | ||
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 1845916 | ||
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 16204191 | ||
| Pubmed | Tissue-specific regulation of Igf2r/Airn imprinting during gastrulation. | 8.01e-06 | 9 | 161 | 3 | 25918552 | |
| Pubmed | A genome-wide association study identifies protein quantitative trait loci (pQTLs). | 9.64e-06 | 61 | 161 | 5 | 18464913 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TNFSF9 LAMA1 CD109 RNF149 ERMP1 ZZEF1 SLC39A13 XYLT2 IGF2R MEGF8 MRC2 SGPL1 ALG9 FHOD1 SCPEP1 ATP2A2 TAPBP PLXNA1 | 1.26e-05 | 1201 | 161 | 18 | 35696571 |
| Pubmed | 1.56e-05 | 11 | 161 | 3 | 9268631 | ||
| Pubmed | 2.08e-05 | 12 | 161 | 3 | 8288260 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24628273 | ||
| Pubmed | Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice. | 2.13e-05 | 2 | 161 | 2 | 10634603 | |
| Pubmed | Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis. | 2.13e-05 | 2 | 161 | 2 | 23943648 | |
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 2.13e-05 | 2 | 161 | 2 | 7705657 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23041318 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 19752236 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 7814888 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 6216475 | ||
| Pubmed | Mutations and selection in the generation of class II histocompatibility antigen polymorphism. | 2.13e-05 | 2 | 161 | 2 | 6589154 | |
| Pubmed | Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. | 2.13e-05 | 2 | 161 | 2 | 20440070 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 7777544 | ||
| Pubmed | A central role for plasminogen in the inflammatory response to biomaterials. | 2.13e-05 | 2 | 161 | 2 | 15456492 | |
| Pubmed | DRB1*03 diversity and DRB3 associations in five major population groups in the United States. | 2.13e-05 | 2 | 161 | 2 | 11872240 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 25409527 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 8704243 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 2497068 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23702659 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 27769832 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 20972469 | ||
| Pubmed | Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. | 2.13e-05 | 2 | 161 | 2 | 22079981 | |
| Pubmed | Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. | 2.13e-05 | 2 | 161 | 2 | 9490683 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 16481742 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18983515 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 34378815 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 11848464 | ||
| Pubmed | Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. | 2.13e-05 | 2 | 161 | 2 | 7586361 | |
| Pubmed | Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. | 2.13e-05 | 2 | 161 | 2 | 21239499 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 10642175 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 12225871 | ||
| Pubmed | Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. | 2.13e-05 | 2 | 161 | 2 | 37971174 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 9884337 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 15620466 | ||
| Pubmed | Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice. | 2.13e-05 | 2 | 161 | 2 | 26473342 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 16320316 | ||
| Pubmed | Selection of mutant µplasmin for amyloid-β cleavage in vivo. | 2.13e-05 | 2 | 161 | 2 | 32694536 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 19155468 | ||
| Pubmed | Description of two new HLA-DRB alleles (DRB1*0310 and DRB3*01012) found in a Spanish infant. | 2.13e-05 | 2 | 161 | 2 | 9234492 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 16103174 | ||
| Pubmed | Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice. | 2.13e-05 | 2 | 161 | 2 | 24411733 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21300353 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 11306011 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 12149246 | ||
| Pubmed | Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis. | 2.13e-05 | 2 | 161 | 2 | 18311818 | |
| Pubmed | Localization of plasminogen in mouse hippocampus, cerebral cortex, and hypothalamus. | 2.13e-05 | 2 | 161 | 2 | 21190118 | |
| Pubmed | A physiological function for apolipoprotein(a): a natural regulator of the inflammatory response. | 2.13e-05 | 2 | 161 | 2 | 18997104 | |
| Pubmed | Growth and behavioral development in plasminogen gene-targeted mice. | 2.13e-05 | 2 | 161 | 2 | 10885855 | |
| Pubmed | Cellular density regulation of plasminogen gene expression in mouse hepatocytes. | 2.13e-05 | 2 | 161 | 2 | 12559391 | |
| Pubmed | Tracking antigen-specific T-cells during clinical tolerance induction in humans. | 2.13e-05 | 2 | 161 | 2 | 20543955 | |
| Pubmed | Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. | 2.13e-05 | 2 | 161 | 2 | 15333838 | |
| Pubmed | Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen. | 2.13e-05 | 2 | 161 | 2 | 16150044 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 11916082 | ||
| Pubmed | Delayed invasion of the kidney and brain by Borrelia crocidurae in plasminogen-deficient mice. | 2.13e-05 | 2 | 161 | 2 | 11500461 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 16200610 | ||
| Pubmed | Role of plasminogen activation in neuronal organization and survival. | 2.13e-05 | 2 | 161 | 2 | 19683575 | |
| Pubmed | Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. | 2.13e-05 | 2 | 161 | 2 | 23555246 | |
| Pubmed | HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy. | 2.13e-05 | 2 | 161 | 2 | 28028136 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18685433 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 31462325 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 30657605 | ||
| Pubmed | HLA-DRB1 and -DRB3 allele frequencies and haplotypic associations in Koreans. | 2.13e-05 | 2 | 161 | 2 | 15041167 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 31690812 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 30254165 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 38328826 | ||
| Pubmed | The unusual DRB1*08:01 haplotype carrying DRB3*02:02 confirmed in a Dutch family. | 2.13e-05 | 2 | 161 | 2 | 23742216 | |
| Pubmed | Reduced transplant arteriosclerosis in plasminogen-deficient mice. | 2.13e-05 | 2 | 161 | 2 | 9819364 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 12083480 | ||
| Pubmed | Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen. | 2.13e-05 | 2 | 161 | 2 | 10604721 | |
| Pubmed | Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice. | 2.13e-05 | 2 | 161 | 2 | 18420257 | |
| Pubmed | Plasminogen alleles influence susceptibility to invasive aspergillosis. | 2.13e-05 | 2 | 161 | 2 | 18566672 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 30282837 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 32978525 | ||
| Pubmed | The generation and characterization of mice expressing a plasmin-inactivating active site mutation. | 2.13e-05 | 2 | 161 | 2 | 20653841 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 12428098 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24732409 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21447263 | ||
| Pubmed | HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion. | 2.13e-05 | 2 | 161 | 2 | 21484216 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24876560 | ||
| Pubmed | Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice. | 2.13e-05 | 2 | 161 | 2 | 24574269 | |
| Pubmed | Spontaneous development of otitis media in plasminogen-deficient mice. | 2.13e-05 | 2 | 161 | 2 | 16956791 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 1543918 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 17267741 | ||
| Pubmed | Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain. | 2.13e-05 | 2 | 161 | 2 | 18215127 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 29990619 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 17293777 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23456978 | ||
| Pubmed | Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. | 2.13e-05 | 2 | 161 | 2 | 10854210 | |
| Cytoband | 6q26 | 3.26e-05 | 18 | 160 | 3 | 6q26 | |
| Cytoband | 10q25.3 | 1.42e-04 | 29 | 160 | 3 | 10q25.3 | |
| GeneFamily | Solute carriers | SLC37A1 SLC16A13 FLVCR1 SLC7A6 SLC39A13 SLC35G4 SLC12A5 SLC35F3 SLC35G3 SLC9B2 SLC10A6 SLC14A2 | 4.65e-06 | 395 | 109 | 12 | 752 |
| GeneFamily | Guanylate cyclase receptors | 7.42e-04 | 7 | 109 | 2 | 343 | |
| GeneFamily | Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis | 1.26e-03 | 9 | 109 | 2 | 430 | |
| GeneFamily | C1-set domain containing | 2.06e-03 | 42 | 109 | 3 | 591 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | ATG16L1 SLC16A13 EPPK1 TNFSF9 TAF1C CD109 ERMP1 SLC7A6 ZZEF1 SLC39A13 ABCB10 MRC2 SGPL1 ALG9 TMEM19 ATP2A2 PLXNA1 | 7.67e-07 | 681 | 157 | 17 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | ATG16L1 SLC16A13 EPPK1 TNFSF9 TAF1C CD109 ERMP1 SLC7A6 ZZEF1 SLC39A13 ABCB10 MRC2 SGPL1 ALG9 TMEM19 ATP2A2 PLXNA1 | 1.18e-06 | 703 | 157 | 17 | MM1055 |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | RASGRP4 TMEM176B ARRDC4 HLA-DRB1 FLVCR1 TEP1 CD93 ABCA6 MAMDC2 ATG4C SCPEP1 ADGRE1 PLXNA1 | 1.01e-05 | 426 | 149 | 13 | GSM605859_500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-08 | 184 | 158 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-08 | 184 | 158 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-08 | 184 | 158 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | CTTNBP2 TMEM176B HLA-DRB1 IRAG1 SLC12A5 CD93 ABCA6 MAMDC2 LPAR6 | 3.60e-08 | 196 | 158 | 9 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-06 | 163 | 158 | 7 | 4b8abbad4df040c895e3afb240759ebbc66b4d0e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.88e-06 | 173 | 158 | 7 | 4efa0878ed1ede8fa5d6c191a76d4f70558ba761 | |
| ToppCell | Mid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.48e-06 | 178 | 158 | 7 | ad187db4c40b9078d54dd915c143e0172b2f47b8 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-06 | 183 | 158 | 7 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | LAM-Myeloid-DC|LAM / Condition, Lineage and Cell class | 4.98e-06 | 188 | 158 | 7 | b4140110c2f7d25fd8a0d2749e33e02003ac4bf2 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.53e-06 | 191 | 158 | 7 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.92e-06 | 193 | 158 | 7 | 4f38aae346ea3b4258744e9dc1e5aeb4fea13d06 | |
| ToppCell | LAM-Myeloid-DC|Myeloid / Condition, Lineage and Cell class | 5.92e-06 | 193 | 158 | 7 | f665cce40053ae5d6e28f9f70ddf78e8598c9514 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-06 | 195 | 158 | 7 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.33e-06 | 195 | 158 | 7 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.77e-06 | 197 | 158 | 7 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | 6.77e-06 | 197 | 158 | 7 | 15b87fd3906d7388c271d30d0c64b1bcc490801c | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | 6.77e-06 | 197 | 158 | 7 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.99e-06 | 198 | 158 | 7 | 7f728ca6d5317890c6fcde3ce6c10c0970d49a05 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.23e-06 | 199 | 158 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 7.47e-06 | 200 | 158 | 7 | 25f4c051c2e869481f33c22ad54de97efac444ad | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 7.47e-06 | 200 | 158 | 7 | da45a85a4667965b24ba824af871157af5b4cd19 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.82e-06 | 135 | 158 | 6 | 4451c44f3ad788437f4e2ae81049fbbab53f967e | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.82e-06 | 135 | 158 | 6 | 45f67f33c8320d9fb6dbceae603b564f6a8ffd1e | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.39e-05 | 86 | 158 | 5 | db67c05c876a5649371c0dc6c941cc371bc2feb8 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.39e-05 | 86 | 158 | 5 | 2778446e035c5585bce28ed0ef93b87b6ad90c6e | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.73e-05 | 152 | 158 | 6 | 32634195048858ae84605c61e43c542d90f7cab5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.73e-05 | 152 | 158 | 6 | 0eb185b2404f015efff1bd140e0c502d714720fb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-05 | 159 | 158 | 6 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-05 | 159 | 158 | 6 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Klk6_(Klk6)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.37e-05 | 96 | 158 | 5 | a48235df1f5526ce3ffc4c0c2ba038eb20229c55 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Klk6_(Klk6)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.37e-05 | 96 | 158 | 5 | 0fc179af7370a29b7bd5d81e1302a479ae72f196 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.37e-05 | 96 | 158 | 5 | c301ecfd67ece8bb12be1b94b614957a58046457 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.37e-05 | 96 | 158 | 5 | 7d402d543ff159c9bb84c00b083e6e18fc0ff786 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-05 | 166 | 158 | 6 | 8d5d09f25e8903d481c2097fed435e69d42ccdb5 | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 3.04e-05 | 168 | 158 | 6 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | severe_influenza-pDC|World / disease group, cell group and cell class (v2) | 3.25e-05 | 170 | 158 | 6 | b9c08af83241666bbdbed9109cadcd088c0f647d | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 170 | 158 | 6 | 067657ca7fcf5a0ffbd168b5c4609a30ca508f22 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 172 | 158 | 6 | 7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab | |
| ToppCell | severe_influenza-pDC|severe_influenza / disease group, cell group and cell class (v2) | 3.71e-05 | 174 | 158 | 6 | d8d2ded5812ed3b3db4109585714a6513c13326a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-05 | 176 | 158 | 6 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 182 | 158 | 6 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 182 | 158 | 6 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.21e-05 | 185 | 158 | 6 | d4ba36bdb8b7e3a62e827269484f89f790eaa5ef | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.21e-05 | 185 | 158 | 6 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 186 | 158 | 6 | aa88d9573a237b2b8e6025fee31f69fbce824497 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.37e-05 | 186 | 158 | 6 | 9673367cb53bafb873a01ef6bda11d9f392ce648 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 186 | 158 | 6 | ecc5acd111a6ee50d59544d1bdd7ed94e2812aae | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.37e-05 | 186 | 158 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.37e-05 | 186 | 158 | 6 | 26458ff8cad5577de4306cffa0ca69eb26940e0d | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.37e-05 | 186 | 158 | 6 | a71397efc68d2916ddc373d92cfd07be58033e1c | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 186 | 158 | 6 | af038994a6c32261f426b0c40c39be4a9099fe43 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-05 | 187 | 158 | 6 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-05 | 187 | 158 | 6 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-05 | 187 | 158 | 6 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.53e-05 | 187 | 158 | 6 | 106f50ad85a92403037214f0e94702230284837f | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.53e-05 | 187 | 158 | 6 | a27aa97aa6508a3ffe92c2b6bb0511a95650a390 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.70e-05 | 188 | 158 | 6 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-05 | 190 | 158 | 6 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-05 | 190 | 158 | 6 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-05 | 190 | 158 | 6 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-05 | 191 | 158 | 6 | 509230f50568e5a8ecf08edc4d58f9e2aa96efe9 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 191 | 158 | 6 | a261f0738d974784bbdd60f23092bfbcca464459 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-05 | 191 | 158 | 6 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 191 | 158 | 6 | 6594398cc8151c73696391a43ac110c10283dab1 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-05 | 191 | 158 | 6 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-05 | 191 | 158 | 6 | de3e9b704621b26836c2ddc39fa3e840dfb4541b | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-05 | 191 | 158 | 6 | 0b3dbbc35d9970d3c749aef16dda59886b960e3d | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 191 | 158 | 6 | 7411b253b16e4d472be0925dee49188f0fd6b0b5 | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.37e-05 | 118 | 158 | 5 | d0dd5c882cd9e0a5eb0cb08e47877292126bd4ae | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1-Trf|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.37e-05 | 118 | 158 | 5 | 4283699cb3ca7a112faa07727dfdc0b0a67fb779 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 6.59e-05 | 193 | 158 | 6 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.78e-05 | 194 | 158 | 6 | 3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.78e-05 | 194 | 158 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.78e-05 | 194 | 158 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | distal-1-Hematologic-IGSF21+_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.78e-05 | 194 | 158 | 6 | f30c866e5f41ee79bdc6b6e08af962d62b199835 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.78e-05 | 194 | 158 | 6 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.98e-05 | 195 | 158 | 6 | 54fde2cfa51ab3a2d48d2426494ca6f0ce77f725 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.98e-05 | 195 | 158 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.98e-05 | 195 | 158 | 6 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.98e-05 | 195 | 158 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 195 | 158 | 6 | 44ac99e33b20a377009b8fef16142050a3e1da51 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.98e-05 | 195 | 158 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.18e-05 | 196 | 158 | 6 | 2a2a93b89dcb98043cb1f8b422ac8c55e2edc37b | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 7.18e-05 | 196 | 158 | 6 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|normal_Lung / Location, Cell class and cell subclass | 7.18e-05 | 196 | 158 | 6 | 4d3a3264b3d781139899448cde3b7a4f214ca14d | |
| ToppCell | ICU-NoSEP-Myeloid-CD16_Mono|ICU-NoSEP / Disease, Lineage and Cell Type | 7.18e-05 | 196 | 158 | 6 | b15abb1c5396d038bab92b048795020199370f44 | |
| ToppCell | BLOOD--(3)_Non_classical_monocytes| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.18e-05 | 196 | 158 | 6 | b5ce99e27c9e87be52c10c022a665bf4df0e8b05 | |
| ToppCell | Multiple_Sclerosis-Myeloid-CD16_Mono|Multiple_Sclerosis / Disease, Lineage and Cell Type | 7.18e-05 | 196 | 158 | 6 | 83011b56780295dff5ded57064b07dcd2f19ea26 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.38e-05 | 197 | 158 | 6 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.38e-05 | 197 | 158 | 6 | 46d8c7e9b3aff70bc58894282d0ec9e87d37235f | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.38e-05 | 197 | 158 | 6 | 1a82e0e74fc5fd71c490d98e8813d719b0b81aa6 | |
| ToppCell | distal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.38e-05 | 197 | 158 | 6 | 52e9dc35dd8cc2605fa4894bb16bb5c6086faa76 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_Resident_macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.59e-05 | 198 | 158 | 6 | 30bf78d4d657cf5140549d3dbf43d4f00482e300 | |
| ToppCell | distal-1-mesenchymal-Alveolar_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.59e-05 | 198 | 158 | 6 | 6594c35ab203dc51462167c61807b0d49fa30fb2 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.80e-05 | 199 | 158 | 6 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.80e-05 | 199 | 158 | 6 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.80e-05 | 199 | 158 | 6 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.80e-05 | 199 | 158 | 6 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.80e-05 | 199 | 158 | 6 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.80e-05 | 199 | 158 | 6 | d58edc5f74970bb26d844746184e4bae7c494d6b | |
| Computational | Genes in the cancer module 445. | 5.59e-06 | 15 | 89 | 4 | MODULE_445 | |
| Computational | Genes in the cancer module 27. | EPOR NTRK2 ADGRB2 MCC RYR1 BRS3 LPAR6 TMPRSS2 ADGRE1 IL3RA IL27RA | 1.59e-04 | 355 | 89 | 11 | MODULE_27 |
| Drug | U0125; Up 200; 1uM; PC3; HG-U133A | 1.11e-06 | 196 | 157 | 10 | 663_UP | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 1.41e-06 | 5 | 155 | 3 | EFO_0003884, EFO_0009324 | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 2.27e-05 | 11 | 155 | 3 | DOID:0080822 (is_implicated_in) | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 4.23e-05 | 37 | 155 | 4 | EFO_0022252 | |
| Disease | cholesterol in small LDL measurement | 1.29e-04 | 49 | 155 | 4 | EFO_0022227 | |
| Disease | phospholipids in medium VLDL measurement | 1.63e-04 | 52 | 155 | 4 | EFO_0022154 | |
| Disease | triglycerides in LDL measurement | 2.18e-04 | 56 | 155 | 4 | EFO_0022320 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 2.18e-04 | 56 | 155 | 4 | EFO_0022279 | |
| Disease | triglycerides to total lipids in small LDL percentage | 2.66e-04 | 59 | 155 | 4 | EFO_0022337 | |
| Disease | plasma plasminogen measurement | 2.71e-04 | 5 | 155 | 2 | EFO_0006309 | |
| Disease | triglycerides in medium LDL measurement | 3.22e-04 | 62 | 155 | 4 | EFO_0022322 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 3.43e-04 | 63 | 155 | 4 | EFO_0022239 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 3.64e-04 | 64 | 155 | 4 | EFO_0022253 | |
| Disease | angiostatin measurement | 4.06e-04 | 6 | 155 | 2 | EFO_0008024 | |
| Disease | extranodal nasal NK/T cell lymphoma | 4.06e-04 | 6 | 155 | 2 | MONDO_0019472 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 4.34e-04 | 67 | 155 | 4 | EFO_0022245 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 4.86e-04 | 69 | 155 | 4 | EFO_0022341 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 5.66e-04 | 7 | 155 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 6.33e-04 | 74 | 155 | 4 | EFO_0022280 | |
| Disease | stem Cell Growth Factor beta measurement | 6.66e-04 | 75 | 155 | 4 | EFO_0008292 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 6.66e-04 | 75 | 155 | 4 | EFO_0022287 | |
| Disease | insulin like growth factor measurement | 7.52e-04 | 8 | 155 | 2 | EFO_0004628 | |
| Disease | myasthenia gravis (is_implicated_in) | 7.52e-04 | 8 | 155 | 2 | DOID:437 (is_implicated_in) | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 7.55e-04 | 34 | 155 | 3 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 7.72e-04 | 78 | 155 | 4 | EFO_0022187 | |
| Disease | Schizophrenia | ACSL6 ACHE HLA-DRB1 NTRK2 LAMA1 CSMD2 TRRAP SLC12A5 ZNF530 PLG ATP2A2 IL3RA TAPBP | 8.14e-04 | 883 | 155 | 13 | C0036341 |
| Disease | Kunitz-type protease inhibitor 2 measurement | 1.20e-03 | 10 | 155 | 2 | EFO_0008200 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.37e-03 | 91 | 155 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.40e-03 | 42 | 155 | 3 | EFO_0022255 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.40e-03 | 42 | 155 | 3 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.50e-03 | 43 | 155 | 3 | EFO_0022290 | |
| Disease | Adenocarcinoma of large intestine | 1.67e-03 | 96 | 155 | 4 | C1319315 | |
| Disease | temporal arteritis | 1.75e-03 | 12 | 155 | 2 | EFO_1001209 | |
| Disease | Connective Tissue Diseases | 2.06e-03 | 13 | 155 | 2 | C0009782 | |
| Disease | phospholipids in medium LDL measurement | 2.19e-03 | 49 | 155 | 3 | EFO_0022183 | |
| Disease | cholesterol in medium LDL measurement | 2.19e-03 | 49 | 155 | 3 | EFO_0022224 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 2.19e-03 | 49 | 155 | 3 | EFO_0022256 | |
| Disease | GDH/6PGL endoplasmic bifunctional protein measurement | 2.39e-03 | 14 | 155 | 2 | EFO_0801619 | |
| Disease | familial hyperlipidemia | 2.40e-03 | 106 | 155 | 4 | MONDO_0001336 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 2.46e-03 | 51 | 155 | 3 | EFO_0022302 | |
| Disease | remnant cholesterol measurement | 2.57e-03 | 108 | 155 | 4 | EFO_0010815 | |
| Disease | total lipids in medium LDL | 2.60e-03 | 52 | 155 | 3 | EFO_0022180 | |
| Disease | total lipids in LDL measurement | 2.60e-03 | 52 | 155 | 3 | EFO_0022308 | |
| Disease | Autistic Disorder | 2.64e-03 | 261 | 155 | 6 | C0004352 | |
| Disease | triglycerides in HDL measurement | 2.75e-03 | 53 | 155 | 3 | EFO_0022317 | |
| Disease | cholesterol in small VLDL measurement | 2.75e-03 | 53 | 155 | 3 | EFO_0022228 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 2.75e-03 | 53 | 155 | 3 | EFO_0022286 | |
| Disease | total lipids in medium VLDL | 2.90e-03 | 54 | 155 | 3 | EFO_0022153 | |
| Disease | peripheral arterial disease | 2.90e-03 | 54 | 155 | 3 | EFO_0004265 | |
| Disease | triglycerides in medium HDL measurement | 2.90e-03 | 54 | 155 | 3 | EFO_0022321 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 2.90e-03 | 54 | 155 | 3 | EFO_0022244 | |
| Disease | lipoprotein A measurement | 2.93e-03 | 112 | 155 | 4 | EFO_0006925 | |
| Disease | free cholesterol measurement | 3.03e-03 | 113 | 155 | 4 | EFO_0008591 | |
| Disease | linoleic acid measurement | 3.08e-03 | 186 | 155 | 5 | EFO_0006807 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 3.12e-03 | 114 | 155 | 4 | EFO_0004574, EFO_0004611 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 3.21e-03 | 56 | 155 | 3 | EFO_0022333 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 3.21e-03 | 56 | 155 | 3 | EFO_0022251 | |
| Disease | phospholipids in VLDL measurement | 3.73e-03 | 59 | 155 | 3 | EFO_0022301 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 3.73e-03 | 59 | 155 | 3 | EFO_0022289 | |
| Disease | triglycerides to total lipids in large HDL percentage | 3.91e-03 | 60 | 155 | 3 | EFO_0022330 | |
| Disease | total lipids in VLDL measurement | 3.91e-03 | 60 | 155 | 3 | EFO_0022314 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 3.91e-03 | 60 | 155 | 3 | EFO_0022237 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 3.93e-03 | 197 | 155 | 5 | EFO_0005680 | |
| Disease | essential hypertension (is_implicated_in) | 3.97e-03 | 18 | 155 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 4.09e-03 | 702 | 155 | 10 | C0009402 | |
| Disease | triglycerides in small VLDL measurement | 4.09e-03 | 61 | 155 | 3 | EFO_0022145 | |
| Disease | free cholesterol in IDL measurement | 4.09e-03 | 61 | 155 | 3 | EFO_0022181 | |
| Disease | free cholesterol in VLDL measurement | 4.09e-03 | 61 | 155 | 3 | EFO_0022276 | |
| Disease | triglycerides in small HDL measurement | 4.29e-03 | 62 | 155 | 3 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 4.29e-03 | 62 | 155 | 3 | EFO_0022169 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 4.29e-03 | 62 | 155 | 3 | EFO_0022339 | |
| Disease | free cholesterol in very large HDL measurement | 4.29e-03 | 62 | 155 | 3 | EFO_0022273 | |
| Disease | hepatitis B virus infection | 4.42e-03 | 19 | 155 | 2 | EFO_0004197 | |
| Disease | toxic shock syndrome (is_marker_for) | 4.42e-03 | 19 | 155 | 2 | DOID:14115 (is_marker_for) | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 4.46e-03 | 126 | 155 | 4 | EFO_0004611, EFO_0010351 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 4.48e-03 | 63 | 155 | 3 | EFO_0022335 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 4.48e-03 | 63 | 155 | 3 | EFO_0022283 | |
| Disease | parental longevity | 4.72e-03 | 494 | 155 | 8 | EFO_0007796 | |
| Disease | triglycerides in small LDL measurement | 4.89e-03 | 65 | 155 | 3 | EFO_0022323 | |
| Disease | cholesterol in large VLDL measurement | 4.89e-03 | 65 | 155 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 4.89e-03 | 65 | 155 | 3 | EFO_0022230 | |
| Disease | ulcerative colitis, Crohn's disease | 4.90e-03 | 20 | 155 | 2 | EFO_0000384, EFO_0000729 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PWSGVVDATTFQSVC | 86 | P22303 | |
| DLFPTIASGCSWTLE | 56 | O60241 | |
| LPAVFTCEGNGSWTG | 3046 | Q7Z408 | |
| SFPAVLTCVGNGTWS | 3266 | Q7Z407 | |
| GPASLARWTLGFCDE | 66 | O95336 | |
| FSAPGFKCGSDWTRV | 526 | Q676U5 | |
| GWEITDTLCVGPVFT | 441 | Q96A70 | |
| GQVWAPEGSTAFKCL | 51 | Q9H6U8 | |
| EWILNICSPFAFTTG | 356 | Q8N139 | |
| GERTAPFCSWFQGVL | 351 | O96024 | |
| DVFDWGSSGPLCVSP | 246 | Q9NPY3 | |
| WPCFLLTSVGTGLAS | 186 | Q12887 | |
| ELAWATACSFGGSRP | 321 | Q9Y305 | |
| VACVWAAASRVPGSL | 26 | Q9NRK6 | |
| WAQKCELAGSVGPFT | 306 | Q96EG1 | |
| QAPGCGELLFDTDTW | 211 | Q8N6M6 | |
| GAIGCIGFSWAASPA | 96 | P20711 | |
| IGFSWAASPACTELE | 101 | P20711 | |
| GDGVCVTFWRSSPLD | 466 | Q6ZW61 | |
| GLCSAFISAVWVAFP | 546 | Q7Z2K6 | |
| PQIEGSALTTDCGWG | 96 | Q96DT6 | |
| GCWFFTSGPVSLSAK | 186 | Q8NCT1 | |
| VLGNPSWTVGCSVDV | 31 | Q5HYI8 | |
| FSPDLWGVSVCTVDG | 256 | O94925 | |
| STCGFDSVLASLPWI | 31 | Q7Z304 | |
| SSTGRPDWTCIVVGF | 146 | Q9H2M9 | |
| ADAINCLGFTWASSP | 96 | P19113 | |
| GCFKDGLPWTRTFST | 26 | Q17RR3 | |
| ATFAITTLWLGPCDI | 371 | Q9HCP6 | |
| GGDLESLCPWESTDF | 1421 | Q6PRD1 | |
| SAVFTVGVLGPWACD | 51 | Q02846 | |
| LCSFLPWSGISSKSG | 221 | Q9H7X0 | |
| AGADVELQCWTSGVP | 1451 | Q8NDA2 | |
| APRSFIFLWCGSGEG | 226 | Q9HCE5 | |
| EPGAVTGSATVTAFW | 251 | A6ND91 | |
| RGCIWEASNSSGVPF | 981 | O43451 | |
| ISPACGAQASWSIFG | 11 | Q9Y6F6 | |
| DVAVSVGGRPCSFSW | 991 | Q9UIW2 | |
| GCFSDTEPWGGTAIR | 26 | P54315 | |
| GLESVQCWIGIPFSA | 21 | Q9H2C5 | |
| LCASDGPGTFESWRS | 696 | Q7Z5P9 | |
| WGAEAVGCSIQLTTP | 61 | Q96LB8 | |
| PTFCDSCSGFLWGVT | 551 | Q8TDF6 | |
| SWLPCIFFSGGVTVG | 246 | O15503 | |
| PAFWTAASLCATGGL | 76 | A8MTQ0 | |
| CSLIPSGAEWARVSA | 286 | Q6UWB1 | |
| WGPAPVFVTSLEACV | 661 | Q7Z7M0 | |
| TTALGGCPSDWIQFL | 966 | Q9UBG0 | |
| SWGDAPTEVVACSGS | 1321 | Q9ULI4 | |
| LFSLLWCAGVPSVTS | 461 | Q8WTR4 | |
| PTFCSHCTDFIWGIG | 46 | P05129 | |
| VCTGVWLTVIGGSAP | 136 | P43657 | |
| VVSWCTGVSTGFLPS | 146 | Q8NGX0 | |
| VASLPETAWGCQGSI | 266 | Q8WWR8 | |
| ETAWGCQGSIVGFPA | 271 | Q8WWR8 | |
| IGSGQKTWTFCGTPE | 601 | Q13237 | |
| IGRGPSSEWVTSDCA | 131 | Q7Z442 | |
| WAEGCFPLLESGDST | 836 | Q86Y26 | |
| ICGGSLIAPSWVLSA | 71 | Q5K4E3 | |
| EVFGWCPVEDGASVS | 171 | Q9UBL9 | |
| CFTATFEIWVEGPLG | 251 | A8MW95 | |
| STCWGLSFVVPGAIV | 216 | P57057 | |
| CSVSGFYPGSIEVRW | 146 | P79483 | |
| FPSGSECHISGWGVT | 441 | Q14520 | |
| PGFAIITQWCEGSSL | 376 | P10398 | |
| SFSACTDGISWPFVL | 1006 | P16615 | |
| DPSGSTWLSAFVLRC | 981 | Q6YHK3 | |
| GAFAVAGCSVQPWES | 526 | P23508 | |
| WFIAVSSEGGCPLIL | 126 | Q9UHA7 | |
| DVDFLSCSWAVGPGA | 116 | P26951 | |
| WGETSDGTLFCPRDA | 66 | Q4AC94 | |
| CAVSALATSQVGAWP | 626 | Q8WZ74 | |
| GVVGPWACDSLFSKA | 56 | P51841 | |
| EGPSAFLCGSSLKWS | 666 | P10643 | |
| PEAASWLLCEVSGFS | 286 | P01880 | |
| CSVSGFYPGSIEVRW | 146 | P01911 | |
| TECTGGCTFTLPGDW | 446 | Q9ULC5 | |
| GCTFTLPGDWTSGHV | 451 | Q9ULC5 | |
| QKFTGAVCWSGPAST | 36 | Q8NI99 | |
| FGKHFCGGTLISPEW | 1841 | P08519 | |
| CGGTLISPEWVLTAA | 1846 | P08519 | |
| FTANPWICISGELGE | 971 | Q6IQ26 | |
| GGLSSPEFSELCIWL | 41 | Q52LJ0 | |
| RALVGWSSGDGIFCP | 136 | Q9Y600 | |
| SVWFGPKEVSTACAT | 226 | Q9Y5Y0 | |
| SVGTNCGIEPWDSGV | 1351 | Q8TEP8 | |
| VTVWTCPTVSRSGGF | 471 | Q86Y33 | |
| VCFWEEAASAGVGPG | 61 | P19235 | |
| GAVRFWCSLPTADTS | 101 | P19235 | |
| DAIFSCAWTGNPSLT | 351 | Q8IZU9 | |
| SPWGCLVGTLTLAAF | 51 | Q5T1A1 | |
| GVSASRFGPCATLWA | 641 | Q9Y613 | |
| DSQPCVLGWESFASG | 366 | Q8WVV5 | |
| VVGCSPAAEETAAWV | 306 | Q96H72 | |
| VRVFAGQEPSCVWAG | 1436 | P21817 | |
| CLPTGWANFGVTSEE | 2656 | P21817 | |
| GVWTGETIPVRTCFG | 426 | Q9UKN5 | |
| RVFGDSWALGQCESP | 1101 | Q3ZCN5 | |
| FSCGGETRVPLWLQS | 201 | Q9H4L5 | |
| LGSWVCGFVAIAVPT | 146 | Q8NGZ6 | |
| SPWVIVIGSFFSTCG | 506 | Q9H2X9 | |
| SIFWLGAREITFPGC | 91 | Q8NGJ2 | |
| LIGWNDGGCPITSFT | 1496 | O60469 | |
| SWYTSAVCPLGVGFD | 2271 | P11717 | |
| AWFPGSGAFRELVSC | 381 | P49591 | |
| FVPGHFSCDVVWGTV | 2031 | Q5T011 | |
| LPSDLLSWSCVGAVG | 246 | Q8N808 | |
| PFGFALEAGCQAWDT | 336 | Q3ZLR7 | |
| LCPTWATDALASVGI | 386 | Q9BXR0 | |
| SWRLPGSESGCLDAV | 351 | A2VEC9 | |
| CNFAGVALGDSWISP | 191 | Q9HB40 | |
| SRSGAVCLWSPEDGL | 356 | Q15572 | |
| TSWVAGCAGGSVPVR | 256 | Q7RTY7 | |
| PLFSSEICAVTGWGS | 691 | Q7RTY7 | |
| LWGSCTFGLPTDTTT | 16 | P00797 | |
| FGVSDVCSSLSWPVG | 506 | P25391 | |
| PVSTGRFKGCSVSLW | 1456 | P58107 | |
| VWSITGSECLPGGNL | 101 | Q86UD5 | |
| WALAACFTPGESQRG | 11 | P02814 | |
| FFKSGELLATWCGSP | 166 | Q9H0K1 | |
| FCGGTLISPEWVLTA | 606 | P00747 | |
| RPSVCIGTVVFSWVG | 136 | Q8NGC5 | |
| SFDDIPWGNLCGFSV | 296 | Q8IY50 | |
| SLGPWTVLSASGCAF | 86 | Q3YBM2 | |
| SRDIFPVGWCSLTGD | 216 | Q96GD3 | |
| TIAGSRPGGISAACW | 391 | O95470 | |
| GSTDIPDWCVVEAGF | 621 | P13798 | |
| WSGDNSPGIEALCAI | 36 | P32247 | |
| TETGFIWSFLGPVCT | 746 | Q14246 | |
| TECTAGCTFTTPGDW | 461 | Q9UKU0 | |
| LGTDITVICPWEAFS | 56 | Q13956 | |
| ARALVWGTAGDSLCP | 151 | Q96M02 | |
| LVVGFWRAAFACPTS | 21 | Q16620 | |
| SRIWCSDPSPGIVAF | 41 | Q16620 | |
| VITWGRGFACVSPGE | 826 | P63136 | |
| LPSDLLSWSCVGAVG | 246 | P0C7Q5 | |
| AAPWVALVARGGCTF | 106 | Q8NC42 | |
| SCPQGSWAFSVSLGE | 111 | Q9HA65 | |
| CGGSIITPEWIVTAA | 281 | O15393 | |
| LISCSSDGSVGLWDP | 2121 | Q99973 | |
| SGWALTFAPTLACLS | 116 | Q7RTY0 | |
| LRDACSLPWDVGSTG | 376 | P98077 | |
| TAVSAGPAVIECWFV | 16 | O15533 | |
| GPAVIECWFVEDASG | 21 | O15533 | |
| WALAACFTPGESQRG | 11 | Q99954 | |
| IATLECSWTLPSLGG | 366 | Q8TEQ6 | |
| ECGVFGCIASGEWPT | 11 | Q06203 | |
| PSGEAGIIWDSICFA | 1406 | Q9H5I5 | |
| VTWITKSFCPGGTDS | 306 | Q9C0C9 | |
| PGCISSVSDWLISIG | 1176 | O94885 | |
| CPGGTISNIFTFWVD | 106 | Q3KNW5 | |
| EAEWSIGFPGSVCDA | 2826 | Q86WI1 | |
| VAAGTSFQVLGPVCW | 11 | Q86VD9 | |
| AVFLACPWAVSGARA | 46 | P41273 | |
| GAIPIEGATEWSDCF | 331 | Q9BV44 | |
| FSWTIPIAVALSCFG | 316 | Q92536 | |
| VDLCAAPGSWSQVLS | 46 | Q9UET6 | |
| ACSAGDTWASEVGPV | 181 | Q96HH6 | |
| TACGLPDVAVSWGLD | 1191 | O43149 | |
| SEGGFSLCHPGWSVV | 101 | Q5T6R2 | |
| WCGAVDEGTPSAESV | 56 | Q6P9A1 | |
| VITWGRGFACVSPGE | 831 | Q9WJR5 | |
| ASPWFAASFCVVGLA | 26 | P21731 | |
| CGDIVWSLAFGSSVP | 106 | Q9Y6I7 | |
| FASFPEGSWEACGSL | 136 | Q6DKI7 | |
| CDNPWTGGVFLVALF | 296 | Q15849 | |
| SVVGVPPGTWAFCLA | 391 | Q15849 | |
| TWGITSCKAPGEAQF | 561 | Q9Y4A5 | |
| LSSFWSVAGLCAIGP | 816 | Q9H1B5 | |
| TADDSGLLCVWRSGP | 186 | Q9H977 | |
| ITWCFLESPLEVSSG | 11 | Q8N3U1 | |
| GVLQGITSWGSEPCA | 221 | P07288 |